Montelukast Prescribing at SAFFRON HEALTH PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,519
Total Quantity
72.9K
NHS Cost
£3.7K
vs National Avg
+267.9%
SAFFRON HEALTH PARTNERSHIP prescribed 2,519 items of Montelukast over the last 12 months at a cost of £3,699 to the NHS. This is 267.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
232
Jul 2026
198
Jul 2026
207
Jul 2026
216
Jul 2026
211
Jul 2026
217
Jul 2026
206
Jul 2026
221
Jul 2026
213
Jul 2026
188
Jul 2026
209
Jul 2026
201
Prescribing Details
| Total Items | 2,519 |
|---|---|
| Total Quantity | 72,940 |
| Total NHS Cost | £3,699 |
| Presentations | 4 different forms |
| vs National Average | +267.9% |
Montelukast Prescribing Comparison
| This practice | 2,519 items |
|---|---|
| National average per practice | 685 items |
| Difference | +267.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.